Navigation Links
Par Pharmaceutical Reports Third-Quarter 2007 Results
Date:12/20/2007

CONDENSED CONSOLIDATED BALANCE SHEETS

(In Thousands, Except Share Data)

(Unaudited)

September 29, December 31,

ASSETS 2007 2006

Current assets:

Cash and cash equivalents $114,161 $120,991

Available for sale debt and marketable

equity securities 173,544 92,120

Accounts receivable, net 108,182 99,043

Inventories 81,049 106,322

Prepaid expenses and other current assets 13,623 15,833

Deferred income tax assets 72,105 72,105

Income taxes receivable 6,605 12,422

Total current assets 569,269 518,836

Property, plant and equipment, at cost

less accumulated depreciation and

amortization 81,902 89,155

Available for sale debt and marketable

equity securities 7,233 7,652

Investment in joint venture 5,774 5,292

Other investments 2,500 16,588

Intangible assets, net 38,719 47,880

Goodwill 63,729 63,729

Deferred charges and other assets 2,879 16,000

Non-current deferred income tax assets, net 57,485 49,545

Total assets $829,490 $814,677

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:

Short-term and current portion of


'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)... Minn., Aug. 29 /PRNewswire-USNewswire/ -- The Hol... Saint Paul suburb of Eagan,will reduce the price ...r,3, from 11 a.m. until 1 p.m. The promotion is ti...tion, and the fleet of flexible fuel vehicles,Gene... guests. There is a,15 gallon limit per flexible f...
(Date:8/29/2008)...may have caused chromosomal change that raises odd..., Aug. 29 (HealthDay News) -- Some Japanese surviv...shima and Nagasaki experienced key genetic changes...oid cancer, new research indicates. , Papillary...ticular genetic mutation involving the so-called B...
(Date:8/29/2008)...N, Mich., Aug. 29 /PRNewswire/ -- In response to r...of chronic wasting disease (CWD),members of the d...atement., With hunting season fast approaching, t...or a deer on a Kent County farm understandably has...s and deer farmers across,the great state of Michi...
(Date:8/29/2008)...CE Mark Opens Market to More Than 30 European Coun...dical, Inc. announced today,that it has successful...SO,13485 and the Medical Device Directive (for mos...of the coveted CE Mark -- or Conformite Europeene ...em. This expands Hoana,s,patient safety reach to i...
Breaking Medicine News(10 mins):Health News:An 'Unconventional' Fuel at an Unbelievable Price: Minnesota Station Cuts Cost of E85 by $1 Per Gallon 2Health News:Some Hiroshima Survivors at Thyroid Cancer Risk 2Health News:Some Hiroshima Survivors at Thyroid Cancer Risk 3Health News:Deer Farm Industry in Michigan Issues Statement on the Recent Chronic Wasting Disease Case Identified on a Kent County Deer Farm 2Health News:Hoana Medical Acquires CE Mark to Expand Patient Safety Technology to European Market 2Health News:Hoana Medical Acquires CE Mark to Expand Patient Safety Technology to European Market 3Health News:Hoana Medical Acquires CE Mark to Expand Patient Safety Technology to European Market 4
...ology projects the total cost of ischemic stroke f... income from younger stroke victims playing a majo...es BASIC and NOMASS, looked only at the costs of i... majority of all strokes. They included the costs...
... here Thursday due to extreme weakness following a... a week ago and was being treated by a private con... very weak prompting the attending physician to ge...o the Heritage Hospital in Varanasi Thursday morni...
...hya Pradesh allegedly died because his parents did... the umbilical cord.// Ram Milan, the father of t...s wife to the government hospital in Satna for a s...other things in store for him. "The nurse on duty...
...vernment in Northern Ireland will lead to the phas...ntation// of an e-prescriptions service. The Dep...ty has announced that community pharmacies across ...n electronic system to transfer prescriptions over...
Other Medicine News:Health News:Stroke Care Cost To Touch $2.2 trillion by 2050 2
(Date:8/28/2008)...re/ -- Blood transfusions are a,valuable treatment...he risk,of donor disease transmission. Researchers...ducts to understand how certain diseases are,trans...od transfusions.,According to a study in sheep pre... the American Society of Hematology, the risk of t...
(Date:8/27/2008)...nters involved in 10-year study, CHICAGO, Aug. 27...tudy,published in the August 28 issue of the New E...lfate administered to women delivering before 32,w...sy by 50 percent. The,Beneficial Effects of Antena...n 18 centers in the U.S., including Northwestern M...
(Date:8/27/2008)...r at The Children,s Hospital at, Montefiore Prov...e and Specialty Services...ts Every Heart Condition, NEW YORK, Aug. 27 /PRNe...ontefiore (CHAM) is bringing the medical miracle o...llowing the recent approval of its,transplant cent...
(Date:8/26/2008)...mafore Pharmaceuticals Inc.,announced data present...ed,Therapies in Cancer in Washington, D.C., showin...argeted PI3 kinase (PI3K) inhibitor SF1126, by,blo...of a very powerful pathway, the PI3/AKT /mTOR path...ncer. Studies have shown that by,inhibiting this p...
Breaking Medicine Technology:Variant of Mad Cow Disease May Be Transmitted by Blood Transfusions, According to Animal Study 2Variant of Mad Cow Disease May Be Transmitted by Blood Transfusions, According to Animal Study 3National Study Shows Magnesium Sulfate Reduces Risk of Cerebral Palsy in Premature Births 2National Study Shows Magnesium Sulfate Reduces Risk of Cerebral Palsy in Premature Births 3Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health 2Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health 3Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health 4SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines 2SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines 3MultiVu Video Feed 3A Podiatrists Keep America Walking 16856 1MultiVu Video Feed 3A Podiatrists Keep America Walking 16856 2Tasker Products Receives USDA Consent to Begin Immediate Commercialization of Tasker Clear Throughout Entire Poultry Processing Operations 16854 1Tasker Products Receives USDA Consent to Begin Immediate Commercialization of Tasker Clear Throughout Entire Poultry Processing Operations 16854 2Tasker Products Receives USDA Consent to Begin Immediate Commercialization of Tasker Clear Throughout Entire Poultry Processing Operations 16854 3Using HR Performance Metrics to Drive Costs Down Across HR Functions 16852 1Using HR Performance Metrics to Drive Costs Down Across HR Functions 16852 2Oncolytics Biotech Inc Collaborators Present Reovirus Research for Pediatric Sarcomas at AACR Annual Meeting 4611 1Oncolytics Biotech Inc Collaborators Present Reovirus Research for Pediatric Sarcomas at AACR Annual Meeting 4611 2
...-Jul 6, 2007 - Cobalis Corp.,(OTCBB:CLSC), a pharm...-allergy medications, today reported preliminary t... for its drug,PreHistin(TM) in patients with moder...s, commonly known as hay fever. The trials,showed ...tin-treated patient groups, thereby leaving no roo...
...ial in non-small cell lung cancer -, LOS ANGELES, ...enetics, Inc. today announced that positive Phase ... the Journal of Clinical,Oncology suggests that lo...s-Complementing 1 (ERCC-1) in patient biopsies,wit...icts for,sensitivity to cisplatin-based chemothera...
Other Medicine Technology:Cobalis Reports Phase III Trial Results for PreHistin in Seasonal,Allergic Rhinitis 2Cobalis Reports Phase III Trial Results for PreHistin in Seasonal,Allergic Rhinitis 3Cobalis Reports Phase III Trial Results for PreHistin in Seasonal,Allergic Rhinitis 4Cobalis Reports Phase III Trial Results for PreHistin in Seasonal,Allergic Rhinitis 5Response Genetics Announces Publication of a Phase III Clinical,Trial Demonstrating That Low Levels of ERCC-1 Help to Predict,Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer 2Response Genetics Announces Publication of a Phase III Clinical,Trial Demonstrating That Low Levels of ERCC-1 Help to Predict,Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer 3Response Genetics Announces Publication of a Phase III Clinical,Trial Demonstrating That Low Levels of ERCC-1 Help to Predict,Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer 4
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
Medicine Products: